- Home
- CDT vs KRKR Comparison
CDT vs KRKR Comparison
Compare CDT & KRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDT
- KRKR
- Stock Information
- Founded
- CDT 2019
- KRKR 2010
- Country
- CDT United States
- KRKR China
- Employees
- CDT N/A
- KRKR N/A
- Industry
- CDT Biotechnology: Pharmaceutical Preparations
- KRKR Business Services
- Sector
- CDT Health Care
- KRKR Consumer Discretionary
- Exchange
- CDT Nasdaq
- KRKR Nasdaq
- Market Cap
- CDT 11.9M
- KRKR 9.6M
- IPO Year
- CDT N/A
- KRKR 2019
- Fundamental
- Price
- CDT $0.11
- KRKR $4.65
- Analyst Decision
- CDT
- KRKR
- Analyst Count
- CDT 0
- KRKR 0
- Target Price
- CDT N/A
- KRKR N/A
- AVG Volume (30 Days)
- CDT 24.0M
- KRKR 21.0K
- Earning Date
- CDT 11-18-2024
- KRKR 12-05-2024
- Dividend Yield
- CDT N/A
- KRKR N/A
- EPS Growth
- CDT N/A
- KRKR N/A
- EPS
- CDT N/A
- KRKR N/A
- Revenue
- CDT N/A
- KRKR $41,654,350.00
- Revenue This Year
- CDT N/A
- KRKR $45.99
- Revenue Next Year
- CDT N/A
- KRKR $31.46
- P/E Ratio
- CDT N/A
- KRKR N/A
- Revenue Growth
- CDT N/A
- KRKR N/A
- 52 Week Low
- CDT $0.10
- KRKR $3.50
- 52 Week High
- CDT $7.83
- KRKR $16.20
- Technical
- Relative Strength Index (RSI)
- CDT 41.52
- KRKR 47.81
- Support Level
- CDT $0.10
- KRKR $4.36
- Resistance Level
- CDT $0.14
- KRKR $5.26
- Average True Range (ATR)
- CDT 0.01
- KRKR 0.53
- MACD
- CDT 0.00
- KRKR -0.03
- Stochastic Oscillator
- CDT 18.06
- KRKR 24.58
About CDT Conduit Pharmaceuticals Inc.
Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being, prioritized by leading biopharmaceutical companies in order to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready in autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.
About KRKR 36Kr Holdings Inc.
36KR Holdings Inc is a holding company and conducts its business mainly through its subsidiaries, a VIE, and subsidiaries of the VIE. The Group is engaging in providing content and business services to new economy participants in the PRC. Its content production process includes content creation, content editing, screening and monitoring, and content distribution. The Group mainly generates revenues from providing online advertising services, enterprise value-added services, and subscription services. The Group's principal operations and geographic markets are substantially located in PRC.